⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of AlphaLife Sciences and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
AlphaLife Sciences
↗New Jersey, USA / Singapore
AlphaLife Sciences is an AI-first technology company that specializes in automating regulatory and medical content authoring for the pharmaceutical and biotechnology industries. Their flagship platform, AuroraPrime, utilizes generative AI to streamline the creation of nonclinical, clinical, CMC, safety, and labeling documentation, aiming to accelerate the drug development lifecycle from lab to market.
The company serves a significant portion of the top 20 global pharmaceutical companies, providing enterprise-grade, compliant, and submission-ready regulatory dossiers. By integrating AI agents into existing life sciences workflows, AlphaLife Sciences focuses on reducing the time and cost associated with complex regulatory filings such as IND, NDA, BLA, and MAA submissions.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:-
Industry:Digital Health
Sub-Industry:AI-powered Regulatory Technology (RegTech)
SIZE & FINANCIALS
Employees:51-200
Founded:2020
Ownership:private
Status:operating
0
CORPORATE STRUCTURE
Key Partnerships:Microsoft, NVIDIA, Veeva, Johnson & Johnson
COMPETITION
Position:Emerging
LINKS
Website:alphalifesci.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with AlphaLife Sciences. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.